Each dose level should be followed for approximately 2 weeks before increasing , allowing time to assess tolerance and monitor for any adverse reactions
TB500 has zero published human trials
These include: Older adults, whose ability to absorb B12 from food naturally decreases with age
They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such

Research Verdict: When to Use Each or Both Choose BPC-157 When Research Focuses On: Gastrointestinal healing and protection Tendon and ligament injuries Nerve regeneration and neuroprotection Situations requiring oral administration Protection from NSAID or other toxic damage Choose TB-500 When Research Focuses On: Cardiac tissue repair and cardioprotection Wound healing and scar reduction Systemic anti-inflammatory effects Muscle regeneration Hair follicle research Consider Combination When: Comprehensive tissue repair is the goal (e.g., complex injury involving multiple tissue types) Maximizing angiogenesis AND cell migration is desired Research hypothesis involves sequential healing phases Mechanistic Rationale for Stacking: The combination addresses different phases of healingBPC-157 promotes blood vessel ingrowth and initial cytoprotection, while TB-500 facilitates the cellular repair and remodeling that follows vascularization

These cofactors work synergistically when injected with Vitamin B12